These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37934550)

  • 1. Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut.
    Dowton A; Doernberg M; Heiman E; Barelli P; Golden M; Wang H; Leventhal J; Morford KL; Sue KL
    J Addict Med; 2023 Nov-Dec 01; 17(6):739-741. PubMed ID: 37934550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA.
    Warp PV; Hauschild M; Serota DP; Ciraldo K; Cruz I; Bartholomew TS; Tookes HE
    Harm Reduct J; 2024 Mar; 21(1):64. PubMed ID: 38491467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Confirmed Case of Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Miami, Florida, USA.
    Warp PV; Hauschild M; Tookes HE; Ciraldo K; Serota DP; Cruz I
    Res Sq; 2023 Jul; ():. PubMed ID: 37547000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xylazine-Associated Wounds and Related Health Concerns Among People Who Use Drugs: Reports From Front-Line Health Workers in 7 US States.
    Carroll JJ
    Subst Use Addctn J; 2024 Apr; 45(2):222-231. PubMed ID: 38258791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xylazine in the drug supply: Emerging threats and lessons learned in areas with high levels of adulteration.
    Quijano T; Crowell J; Eggert K; Clark K; Alexander M; Grau L; Heimer R
    Int J Drug Policy; 2023 Oct; 120():104154. PubMed ID: 37574646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review.
    Zhu DT
    Harm Reduct J; 2023 Sep; 20(1):131. PubMed ID: 37700329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis.
    Friedman J; Montero F; Bourgois P; Wahbi R; Dye D; Goodman-Meza D; Shover C
    Drug Alcohol Depend; 2022 Apr; 233():109380. PubMed ID: 35247724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia, Pennsylvania, USA.
    Malayala SV; Papudesi BN; Bobb R; Wimbush A
    Cureus; 2022 Aug; 14(8):e28160. PubMed ID: 36148197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings.
    Perrone J; Haroz R; D'Orazio J; Gianotti G; Love J; Salzman M; Lowenstein M; Thakrar A; Klipp S; Rae L; Reed MK; Sisco E; Wightman R; Nelson LS
    Ann Emerg Med; 2024 Jul; 84(1):20-28. PubMed ID: 38493376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xylazine, a Veterinary Tranquilizer, Detected in 42 Accidental Fentanyl Intoxication Deaths.
    Nunez J; DeJoseph ME; Gill JR
    Am J Forensic Med Pathol; 2021 Mar; 42(1):9-11. PubMed ID: 33031124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report.
    Ehrman-Dupre R; Kaigh C; Salzman M; Haroz R; Peterson LK; Schmidt R
    J Addict Med; 2022 Sep-Oct 01; 16(5):595-598. PubMed ID: 35020700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xylazine: A Drug Adulterant of Clinical Concern.
    Edinoff AN; Sall S; Upshaw WC; Spillers NJ; Vincik LY; De Witt AS; Murnane KS; Kaye AM; Kaye AD
    Curr Pain Headache Rep; 2024 May; 28(5):417-426. PubMed ID: 38507135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xylazine and Adulterants in the Evolving Drug Supply: Urgent Call for Responsive Education Models.
    Jawa R; Murray S; Blakemore S; Ventura AS; Hristova T; Wilder A; Shang M; LaBelle C
    Subst Use Addctn J; 2024 Apr; 45(2):168-175. PubMed ID: 38375666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xylazine Adulteration of the Heroin-Fentanyl Drug Supply : A Narrative Review.
    D'Orazio J; Nelson L; Perrone J; Wightman R; Haroz R
    Ann Intern Med; 2023 Oct; 176(10):1370-1376. PubMed ID: 37812779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Analysis of Drugs: A Pilot Surveillance System To Detect Changes in the Illicit Drug Supply To Guide Timely Harm Reduction Responses - Eight Syringe Services Programs, Maryland, November 2021-August 2022.
    Russell E; Sisco E; Thomson A; Lopes J; Rybak M; Burnett M; Heilman D; Appley MG; Gladden RM
    MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(17):458-462. PubMed ID: 37104171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Management of Xylazine Overdose With Naloxone.
    Morris J; Hoang D
    Cureus; 2024 Apr; 16(4):e57638. PubMed ID: 38707050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips.
    Reed MK; Imperato NS; Bowles JM; Salcedo VJ; Guth A; Rising KL
    Drug Alcohol Depend Rep; 2022 Sep; 4():100074. PubMed ID: 36846574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illicit Drugs May Contain Veterinary Tranquilizer.
    Aschenbrenner DS
    Am J Nurs; 2023 Mar; 123(3):20-21. PubMed ID: 36815816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Priorities to Improve Treatment of Patients Exposed to Xylazine-fentanyl: Rapid Communication from a National Institute on Drug Abuse Center for the Clinical Trials Network Meeting.
    Haroz R; Huntley K; Perrone J
    J Addict Med; 2024 Jan-Feb 01; 18(1):1-3. PubMed ID: 37874651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
    Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D
    Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.